^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Uveal Melanoma |
| Drug: | Opdivo (nivolumab) (PD1 inhibitor) + Yervoy (ipilimumab) (CTLA4 inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Uveal melanoma: Other recommended regimens…Immunotherapy…Nivolumab/ipilimumab
